These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2418132)

  • 1. Interferon inhibits prostaglandin E2 synthesis and stimulates (2'-5')oligoadenylate synthetase activity in peripheral blood mononuclear cells of inflammatory bowel disease patients.
    Rachmilewitz D; Karmeli F; Panet A
    J Interferon Res; 1985; 5(4):629-35. PubMed ID: 2418132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease.
    Stalnikowicz R; Goder K; Karmeli F; Fiocchi C; Rachmilewitz D
    Gut; 1985 Jun; 26(6):556-61. PubMed ID: 2408970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells.
    Bruchelt G; Beck J; Schilbach-Stückle K; Koscielniak E; Treuner J; Niethammer D
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):879-88. PubMed ID: 2450958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel.
    Rachmilewitz D; Ligumsky M; Haimovitz A; Treves AJ
    Gastroenterology; 1982 Apr; 82(4):673-9. PubMed ID: 6949849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.
    Moritz T; Weissmann B; Grünewald B; Hust H; Kummer G; Niederle N
    Mol Biother; 1992 Jun; 4(2):97-102. PubMed ID: 1381190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (2'-5')Oligoadenylate synthetase activity in intestinal mononuclear and epithelial cells of inflammatory bowel disease patients.
    Rachmilewitz D; Stalnikowicz R; Karmeli F; Youngman K; Fiocchi C
    Scand J Gastroenterol; 1988 Oct; 23(8):941-7. PubMed ID: 3201131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
    Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
    Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
    Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
    Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
    Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of serum 2-5AS activity and NK cell activity in the patients with Crohn's disease and ulcerative colitis].
    Suzuki H; Sata M; Yano Y; Kamoi S; Ikeda H; Sasaki E; Toyonaga A; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1988 Jan; 85(1):14-9. PubMed ID: 3373766
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity.
    Shindo M; Iwata A; Okuno T; Matsumoto M; Takeda M; Arai K; Sokawa Y
    Gastroenterol Jpn; 1989 Dec; 24(6):670-5. PubMed ID: 2481600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
    Millar BC; Bell JB
    Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2-5 AS activity in serum and peripheral blood mononuclear cells for chronic active hepatitis C and the relationship to clinical outcome of interferon therapy].
    Toda K; Kumagai N; Iwabuchi N; Suzuki T; Saito H; Morizane T; Hibi T; Ishii H; Tsuchimoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Oct; 20(5):428-36. PubMed ID: 9391306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.
    Schattner A; Wallach D; Merlin G; Hahn T; Levin S; Ramot B; Revel M
    J Interferon Res; 1982; 2(3):355-61. PubMed ID: 6182252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc status in inflammatory bowel disease.
    Ainley CC; Cason J; Carlsson LK; Slavin BM; Thompson RP
    Clin Sci (Lond); 1988 Sep; 75(3):277-83. PubMed ID: 3416562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease.
    Zifroni A; Treves AJ; Sachar DB; Rachmilewitz D
    Gut; 1983 Jul; 24(7):659-64. PubMed ID: 6345283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.